Tag: Acute Promyelocytic Leukemia

February 13, 2018

Cancer Therapies to Reach $26.61 billion by 2025, Report Says

A new report by Grandview Research suggests that global novel drug delivery systems (NDDS) in cancer therapies will reach $26.61...
May 23, 2017

OncBioMune Begins Working with Tretinoin

OncBioMune Pharmaceuticals kicked off its formulation working with tretinoin in order to treat Acute Promyelocytic Leukemia.
April 20, 2017

OncBioMune Inks Tretinoin Licensing Agreement

OncBioMune Pharmaceuticals signs licensing agreement for rights to tretinoin, an oral drug for acute promyelocytic leukemia.